YULETIDE SECURITY: ENUGU POLICE OPERATIVES BUST ARMED ROBBERY AND ONE-CHANCE SYNDICATE, ARREST FIVE SUSPECTS, RECOVER IMITATION GUN, STOLEN TRICYCLES AND OTHER EXHIBITS. (PHOTO). #PRESS RELEASE.

Image
 ENUGU STATE POLICE COMMAND PRESS RELEASE YULETIDE SECURITY: ENUGU POLICE OPERATIVES BUST ARMED ROBBERY AND ONE-CHANCE SYNDICATE, ARREST FIVE SUSPECTS, RECOVER IMITATION GUN, STOLEN TRICYCLES AND OTHER EXHIBITS Operatives of the Enugu State Police Command attached to the Anti-Cultism Tactical Squad have arrested five armed robbery and one-chance criminal suspects in a series of coordinated operations and investigations conducted between 22nd November and 1st December 2025. The suspects are Ikechukwu Patrick (male, 19), Odoh David (male, 21), Izuchukwu Ogbodo (male, 37), Charles Ekenechukwu Egwuatu (male, 39), and Justina Dike (female, 37). Exhibits recovered from them include an imitation gun, four stolen tricycles, a scissors blade, multiple master keys, and several SIM cards. Patrick and Odoh were first arrested on 22nd November 2025 with the assistance of the Neighbourhood Watch Group. An imitation gun and a scissors blade were recovered from them. They confessed to belonging to...

GENE THERAPY OFFERS NEW SICKLE CELL CURE IN THE U. S. (PHOTO).


 Gene Therapy Offers New Sickle Cell Cure in the US


Sebastien Beauzile, a 21-year-old from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell anemia using the groundbreaking Lyfgenia gene therapy.


Administered at Cohen Children’s Medical Center, this innovative treatment provides hope for many suffering from the painful genetic disorder, Forbes reported on Sunday.


A Lifelong Battle

Sickle cell anemia causes abnormally shaped red blood cells, leading to severe pain and potential organ damage. Beauzile, diagnosed at just four months old, endured frequent hospitalizations due to intense pain crises, which he described as “10 out of 10” in severity.


Gene Therapy Breakthrough

Developed by Bluebird Bio and approved by the FDA in December 2023, Lyfgenia works by extracting a patient’s blood stem cells, genetically modifying them to include functional hemoglobin genes, and reinfusing them into the bloodstream. This cutting-edge approach marks a major step forward in treating sickle cell disease.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.